| Primary information |
|---|
| sequence ID | Seq_6708 |
| Peptide sequence | RQFTSSSSM |
| CancerPDF_ID | CancerPDF_ID12091, CancerPDF_ID12661, |
| PMID | 26992070,26992070 |
| Protein Name | "Keratin, type I cytoskeletal 14","Keratin, type I cytoskeletal 14" |
| UniprotKB Entry Name | K1C14_HUMAN,K1C40_HUMAN |
| Fluid | Serum,Serum |
| M/Z | 1029.4549,NA |
| Charge | NA,NA |
| Mass (in Da) | 1030.465746,1046.458788 |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | LC-MS/MS,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | FDR 1 %,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID12091, CancerPDF_ID12661, |
| p-Value | NA,NA |
| Software | SEQUEST and Maxquant,"Maxquant,Proteome Discoverer" |
| Length | 9,9 |
| Cancer Type | Melanoma,Melanoma |
| Database | SwissProt Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 8 cancer samples and 4 healthy samples,8 cancer samples and 4 healthy samples |
| Regulation | "Present in 2 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples.","Present in 2 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples." |
| Validation | na,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |